How to Buy Kiora Pharmaceuticals Stock
Kiora Pharmaceuticals Inc
Kiora Pharmaceuticals, Inc. , a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States.
Kiora Pharmaceuticals stock last closed at $3.06, down 0.36% from the previous day, and has decreased 36.18% in one year. It has overperformed other stocks in the Biotechnology industry by 0.43 percentage points. Kiora Pharmaceuticals stock is currently +21.91% from its 52-week low of $2.51, and -44.86% from its 52-week high of $5.55.
As of May 23, 2025, there are 3.04M KPRX shares outstanding. The market value of KPRX is $9.31M. In the past 24 hours, 3110 KPRX shares were traded.
How to Buy Kiora Pharmaceuticals Stock
Not sure how to invest in Kiora Pharmaceuticals stock? Here's how.
- Choose where to buy Kiora Pharmaceuticals stock: You need to decide on an online brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you determine where to buy Kiora Pharmaceuticals stock.
- Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Put funds into your brokerage account: Choose your payment method and add your info.
- Analyze Kiora Pharmaceuticals stock: The Kiora Pharmaceuticals ticker symbol is KPRX. Is Kiora Pharmaceuticals stock a good investment? Should you buy shares of KPRX? How do KPRX's underlying business fundamentals look? Do top analysts think Kiora Pharmaceuticals is a good buy? Why has KPRX's stock price moved recently? (Hint: Our stock research tools can help you figure out if KPRX is a good stock to buy).
- Place your KPRX buy order: Decide if you will purchase KPRX shares at the current market price or use a limit order to purchase KPRX stock at a given price.
- Get notifications regarding your investment in KPRX: Create a watchlist to key updates about your position in Kiora Pharmaceuticals shares.
Step 1: Choose where to buy Kiora Pharmaceuticals stock
You will need an online brokerage account to access the NASDAQ market and buy KPRX stock.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best place to buy stocks. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world markets: From Technology to Healthcare, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've selected the right brokerage, the next step is to fill out some personal details so you can buy KPRX today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to open your new brokerage account.
- Send your info by hitting the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you've finished signing up on the best stock trading app, you need to deposit funds:
Watch this video walkthrough to see the process of depositing funds into your new investment account.
Step 4: Analyze Kiora Pharmaceuticals stock
After you have selected the best place to buy Kiora Pharmaceuticals stock, it's absolutely critical to evaluate their stock before you invest, so you actually wrap your head around the risk as well as the opportunity.
Overview of key KPRX info
Kiora Pharmaceuticals Fundamentals
WallStreetZen was designed to help everyday investors do more accurate fundamental analysis quickly.
You can see all of the due diligence checks on KPRX's stock page.
What is the fair value of KPRX stock?
Investors use many financial metrics, analyses, models, and charts to gauge KPRX's fair value.
Using relative valuations methods:
- KPRX could be undervalued based on its P/B ratio of 0.39x, relative to Biotechnology industry P/B ratio of 4.29x
You can access more valuation research on KPRX's stock here.
KPRX Financial Summary
Positive Financial Indicators:
- There are more short-term assets than short-term liabilities on the KPRX balance sheet.
- There are more short-term assets than long-term liabilities on the KPRX balance sheet.
- KPRX has cash burn of 7724908. It has enough cash and short-term investments to cover this for at least one year.
- KPRX has $24.11M in cash and short term investments. This is sufficient to cover its annual cash burn of $7.72M.
Negative Financial Indicators:
- Total KPRX debt is higher than 5 years ago, relative to shareholder equity.
- KPRX has a relatively high debt to equity ratio of 0.44.
- KPRX profit margin has gone down from 14.2% to -60,257.3% in the past year.
Is it a good time to buy Kiora Pharmaceuticals stock, according to Wall Street analysts?
Out of 1 Equities analysts who monitor KPRX, the consensus analyst rating on Kiora Pharmaceuticals is a Buy
Please note that analyst ratings are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are saying on the Kiora Pharmaceuticals stock forecast page.
Metrics for Advanced KPRX Traders
KPRX Revenue
Last year, KPRX revenue was $20.00k. In the last 4 year, KPRX's revenue has increased by 13.48% per year. This was slower than the Biotechnology industry average of 40.67%.
You can research KPRX's earnings and revenue performance here.
Are KPRX executives and large shareholders buying or selling the stock?
In the last 12 months, executives and large shareholders at KPRX have bought more shares than they have sold.
Carmine N. Stengone, Director of KPRX, was the latest KPRX insider to buy. They bought $4,600.00 worth of KPRX shares on Sep 11, 2024.
Learn more about who owns KPRX shares here.
Can I get consistent income from KPRX stock?
No, Kiora Pharmaceuticals doesn't provide an income stream by paying out dividends.
What do other investors have to say about KPRX?
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Place your KPRX buy order
You have two primary order types:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are usually the easiest way to buy. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a specific dollar amount, place a limit order.
Hit the Open button and eToro will place the order.
If you require additional help with buying stocks on eToro, click the how to video below:
Step 6: Get notifications regarding your investment in KPRX
Now that you own some shares in KPRX, you'll want to keep up with your new stock purchase.
Add KPRX to a watchlist to track your KPRX stock.
KPRX Feed
How to Buy Stock in Kiora Pharmaceuticals
To reiterate, here are the 6 steps for buying Kiora Pharmaceuticals stock:
- Choose where to buy Kiora Pharmaceuticals stock
- Create a brokerage account
- Put funds into your brokerage account
- Analyze Kiora Pharmaceuticals stock
- Place your KPRX buy order
- Get notifications regarding your investment in KPRX
If you require a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to keep an eye on your new investment in Kiora Pharmaceuticals, click the button below.
Other "How To" Guides You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.